LONDON --(BUSINESS WIRE)--Feb. 24, 2021-- LivaNova PLC (NASDAQ: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter and full-year ended December 31, 2020 . For the fourth quarter of 2020, worldwide sales from continuing operations were $269.6

LONDON --(BUSINESS WIRE)--Jan. 20, 2021-- LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its fourth quarter and full-year 2020 results on Wednesday, February 24, 2021 at 1 p.m.   London time ( 8 a.m.